ResearcherWayne State UniversityNo recent work listed
Archana B. Thakur
Matched on ORCID iD 0000-0003-3876-9555; OpenAlex author ID A5027869313. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 3
- Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness. Co-author DOI 10.1080/2162402x.2021.1930883↗
- Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients. First author DOI 10.1080/2162402x.2020.1773201↗
- Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS) Co-author DOI 10.1186/2051-1426-3-s2-p55↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lawrence G. Lum · 3 shared papers, 2015–2021 · strength 0.29
- Paper Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chem… DOI 10.1080/2162402x.2021.1930883↗
- Paper Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancre… DOI 10.1080/2162402x.2020.1773201↗
- Paper Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated… DOI 10.1186/2051-1426-3-s2-p55↗
- Minsig Choi · 2 shared papers, 2015–2020 · strength 0.15
- Paper Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancre… DOI 10.1080/2162402x.2020.1773201↗
- Paper Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated… DOI 10.1186/2051-1426-3-s2-p55↗
- Anthony Frank Shields · 2 shared papers, 2015–2020 · strength 0.15
- Paper Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancre… DOI 10.1080/2162402x.2020.1773201↗
- Paper Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated… DOI 10.1186/2051-1426-3-s2-p55↗
- Philip A. Philip · 2 shared papers, 2015–2020 · strength 0.15
- Paper Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancre… DOI 10.1080/2162402x.2020.1773201↗
- Paper Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated… DOI 10.1186/2051-1426-3-s2-p55↗
- Hemchandra Mahaseth · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.